Hyderabad-based biopharmaceutical company Suven Life Sciences Ltd said it secured two product patents from Japanese Patent Office (JPO) for its new chemical entities (NCE's) which is for the treatment of disorders associated with neurodegenerative diseases. The patents are valid till 2022. With these a total of three Japanese product patents are granted to Suven, the company said in a statement to the exchanges.
According to the invention patent disclosure, the compounds are useful in the treatment of cognitive impairment associated with neurodegenerative disorders like Alzheimer's disease, attention deficient hyperactivity disorder (ADHD), Huntington's disease, Parkinson and Schizophrenia. These granted patents are exclusive intellectual property of Suven and are achieved through the internal drug discovery research efforts. Products out of these inventions may be out-licensed at the stage of clinical phase-I or phase-II, it added.
On Wednesday, Suven shares ended 4.9% higher at Rs29 on the Bombay Stock Exchange, while the benchmark Sensex closed at 0.3% up at 17,462 points.
Inside story of the National Stock Exchange’s amazing success, leading to hubris, regulatory capture and algo scam
Fiercely independent and pro-consumer information on personal finance.
1-year online access to the magazine articles published during the subscription period.
Access is given for all articles published during the week (starting Monday) your subscription starts. For example, if you subscribe on Wednesday, you will have access to articles uploaded from Monday of that week.
This means access to other articles (outside the subscription period) are not included.
Articles outside the subscription period can be bought separately for a small price per article.
Fiercely independent and pro-consumer information on personal finance.
30-day online access to the magazine articles published during the subscription period.
Access is given for all articles published during the week (starting Monday) your subscription starts. For example, if you subscribe on Wednesday, you will have access to articles uploaded from Monday of that week.
This means access to other articles (outside the subscription period) are not included.
Articles outside the subscription period can be bought separately for a small price per article.
Fiercely independent and pro-consumer information on personal finance.
Complete access to Moneylife archives since inception ( till the date of your subscription )
